← brief for 2026-08-11 · Slowing decline

The HFpEF-ABA Score, Incident Heart Failure, and Finerenone in Chronic Kidney Disease with Type 2 Diabetes.

Article C Peer reviewed Observational

Key takeaways

This study checked whether a heart-failure risk score can predict who benefits from finerenone, a kidney and heart drug, in people who have both kidney disease and type 2 diabetes. It found a link between the score and heart-failure risk. Because this is an analysis of existing data, it shows a pattern, not proof that the score causes anything.

Who did this work

Inciardi RM · Ostrominski JW · Claggett BL · Brinker M · Filippatos G · Lay-Flurrie J · Glasauer A · Scalise A · Rossing P · Ruilope LM · Anker SD · Pitt B

Source

Article · PubMed, the drug frontier · 2026 Aug 10
https://pubmed.ncbi.nlm.nih.gov/42575462/